Likes Subject
BioRestorative Therapies, Inc. Releases Year-End Message DDA 12/20/21 6:24 AM
Yeah, sure. The "assumed" offering price is trader59 11/04/21 11:41 AM
They're still increasing their position. You're not going
Bullish
Bullish
DDA 11/24/22 7:55 AM
Got an honest question for ProAdviser , what Rider25 11/18/22 11:25 PM
And the proxy vote results are in. Swamp_gas 11/10/22 9:03 AM
I'm surprised, really, if only because Auctus still trader59 11/07/22 4:51 PM
Yep there swimming with the fish BRTX trial Powerstreet 11/07/22 4:24 PM
I guess they've given up on the trial? trader59 11/01/22 8:53 PM
Update on insider trading. I ll be back 10/17/22 11:52 AM
This Company is going nowhere Powerstreet 10/04/22 3:12 PM
A conference? They're attending a conference and trader59 09/27/22 9:32 AM
I haven't started back in yet, But I 50 MIL STRONG 09/23/22 4:06 PM
I know where, but. Tell us. 50 MIL STRONG 09/23/22 4:04 PM
I added 902. Still far from Lance's number though. DDA 09/23/22 3:58 PM
And where'd they come from? trader59 09/23/22 3:57 PM
At this time, he is holding $486,303.86 worth. 50 MIL STRONG 09/23/22 3:45 PM
Looks like the CEO is spending large on trader59 09/23/22 3:12 PM
That was such a brutally nasty reverse split Rider25 08/27/22 12:22 AM
Back when this was otc, Should had never PM617 08/25/22 2:35 PM
I would applaud that ... DDA 08/25/22 2:30 PM
Looking for $23 to get my money back. PM617 08/25/22 9:22 AM
It's a buy @ $1.75 I willing Powerstreet 08/22/22 1:49 PM
10Q shows about $18M left in cash, but trader59 08/15/22 10:34 PM
Let's go BRTX will be buying as soon Powerstreet 07/22/22 8:01 AM
I do the same ... so while I'm DDA 07/19/22 6:31 AM
Cool. Those get recorded as "sells" in Jayman5000 07/07/22 12:57 PM
Strange... most of the time I buy at declaes 07/07/22 12:35 PM
Well, insiders still buying, so I'm doing the same DDA 07/06/22 9:27 AM
LMAO! Subliminal messaging! Watch out for the distractions! 50 MIL STRONG 07/01/22 11:05 AM
Understanding the difference between the bid and the Jayman5000 07/01/22 10:59 AM
I'm glad I wasn't one of the many 50 MIL STRONG 07/01/22 10:52 AM
Not for me, I understand the difference between Jayman5000 07/01/22 10:41 AM
Understanding the difference between a buy at the Jayman5000 07/01/22 7:20 AM
Sells or Buys, that is the question. I ll be back 06/30/22 6:30 PM
The ihub trades page has a question mark Jayman5000 06/30/22 4:23 PM
Everyone with any math sense knows that's just 50 MIL STRONG 06/30/22 4:00 PM
There is a difference between sells into the Jayman5000 06/30/22 3:57 PM
Oh, please... Same old OTC crap rationalization. trader59 06/30/22 3:56 PM
Again, literally impossible! Every trade has a buy 50 MIL STRONG 06/30/22 3:52 PM
Where's ProAdviser at , no words of wisdom Rider25 06/30/22 3:48 PM
Yeah, you're right, poor choice of words on trader59 06/30/22 3:45 PM
That's literally impossible if there is actually trade volume! 50 MIL STRONG 06/30/22 3:29 PM
Even the announcement of patient enrollment is being trader59 06/30/22 2:02 PM
It will happen. whistle pig 06/27/22 9:11 PM
I will be buy when we go under Powerstreet 06/27/22 12:53 PM
Error NWriter 06/24/22 6:46 AM
Just more "sell on the news" with the markets...LOL I ll be back 06/22/22 3:55 PM
Don't understand why the price is going down. DDA 06/22/22 3:51 PM
Nice to see Lance lining up the ducks I ll be back 06/22/22 9:26 AM
BioRestorative Therapies Announces Clinical Trial Contract with Second DDA 06/22/22 9:21 AM
Form S3 out. At the same time insiders DDA 06/18/22 5:05 AM
Come to daddy ... Taking 3.5's DDA 06/16/22 3:19 PM
Likes Subject

trader59
11/04/21 11:41 AM
Swamp_gas
11/10/22 9:03 AM
Powerstreet
11/07/22 4:24 PM
trader59
11/01/22 8:53 PM
I ll be back
10/17/22 11:52 AM
Powerstreet
10/04/22 3:12 PM
50 MIL STRONG
09/23/22 4:06 PM
50 MIL STRONG
09/23/22 4:04 PM
trader59
09/23/22 3:57 PM
50 MIL STRONG
09/23/22 3:45 PM
trader59
09/23/22 3:12 PM
DDA
08/25/22 2:30 PM
PM617
08/25/22 9:22 AM
Powerstreet
08/22/22 1:49 PM
trader59
08/15/22 10:34 PM
Powerstreet
07/22/22 8:01 AM
DDA
07/19/22 6:31 AM
Jayman5000
07/07/22 12:57 PM
declaes
07/07/22 12:35 PM
50 MIL STRONG
07/01/22 10:52 AM
I ll be back
06/30/22 6:30 PM
Jayman5000
06/30/22 4:23 PM
50 MIL STRONG
06/30/22 4:00 PM
Jayman5000
06/30/22 3:57 PM
whistle pig
06/27/22 9:11 PM
Powerstreet
06/27/22 12:53 PM
NWriter
06/24/22 6:46 AM
I ll be back
06/22/22 9:26 AM
DDA
06/16/22 3:19 PM

BioRestorative Therapies Inc. (BRTX)

Followers
503
Posters
Posts (Today)
0
Posts (Total)
63264
Created
11/16/07
Type
Free
Moderators DDA Powerstreet trader59
 
 
Welcome to the BRTX Dilution Machine !

The rocky road to NASDAQ....

BRTX uplisted to NASDAQ after a 4000:1 reverse split to pop the price from the $0.003's up to $13+ per share.  The O/S was reduced in the process to approximately 870k shares.  An underwritten stock offering sold 2.3M "units" consisting of 1 share of common stock and 1 warrant with a strike price of $10, each unit selling for $10.  This netted the company over $20M for corporate purposes and to begin the FDA phase 2 trial approved in 2017.

The day before NASDAQ, the PPS was $13.50.
The first day of NASDAQ, the PPS closed at $7.74
Currently the stock trades in the low $5 range.
The O/S with the offering and post-split numbers would have been 3.1-3.2M shares, but currently sits at 3.5M shares.

Auctus, their primary lender throughout the bankruptcy and uplisting process, was given over 1.6M "units" at offering price in exchange for $8.8M of debt and $7.3M their dirt cheap warrants from the bankrupty were "deemed" to be valued, subject to a lockup period of 4 months and a limitation on becoming a beneficial (5%) owner.  Auctus can begin to sell stock in early March.

This has been a toxic lender ATM through the bankruptcy and now the uplisting.
Just prior to the bankruptcy, the lenders converted debt into 1.6B (pre-split) shares at a high discount.
In the bankruptcy "plan" controlled by Auctus, those lenders were given stock (over 1B pre-split shares) in exchange for their outstanding debt at a PPS of a penny after it had been pumped up to 2-3 cents.  Those unsecured, toxic lenders profited off of loans that would have been wiped away in the originally planned liquidation.
Auctus took convertible notes for their loans prior, through, and after the bankruptcy, with warrants attached with strike prices of $0.0005 and $0.0010 ($2 and $4 respectively split adjusted).  The stock had become illiquid just prior to the uplisting, making it difficult to execute and profit from the warrants.  So they made a deal for the units in the offering.

The company now has cash for general operations and to advance the phase 2 trial of BRTX-100.  They'll require substantial more funding as that trial proceeds and to advance their other objectives.  This is an excerpt from the prospectus issued for the stock offering (Page 13 of https://www.otcmarkets.com/filing/html?id=15337301&guid=Caxwk6_tBebdB3h )

We will need to obtain a significant amount of financing to initiate and complete our clinical trials and implement our business plan.

Since our inception, we have not generated revenues from our operations and have funded our operations through the sale of our equity securities and debt securities. The implementation of our business plan, as discussed in this prospectus under the caption “Business,” will require the receipt of sufficient equity and/or debt financing to purchase necessary equipment, technology and materials, fund our clinical trials and other research and development efforts and otherwise fund our operations. We anticipate that we will require approximately $12,000,000 in financing to complete a Phase 2 clinical trial using BRTX-100. We anticipate that we will require approximately $45,000,000 in further additional funding to complete our clinical trials using BRTX-100 (assuming the receipt of no revenues). We will also require a substantial amount of additional funding to implement our other programs described in this prospectus under the caption “Business,” including our metabolic ThermoStem Program, and fund general operations. The net proceeds of this offering will not be sufficient to satisfy the foregoing needs. No assurance can be given that the anticipated amounts of required funding are correct or that we will be able to accomplish our goals within the timeframes projected. In addition, no assurance can be given that we will be able to obtain any required financing on commercially reasonable terms or otherwise. In the event we do not obtain the financing required for the above purposes, we may have to curtail our development, marketing and promotional activities, which would have a material adverse effect on our business, financial condition and results of operations, and ultimately we could be forced to discontinue our operations and liquidate.



 


Image

 


A OF JULY 2020, BRTX AND AUCTUS FUND LLC HAS PARTNERD ON A NEW BANKRUPTCY

REORGANIZATION PLAN IN WHICH SHAREHOLDERS WILL NOT LOSE 100 % OF THEIR SHARES. 

Biorestorative Therapies Website: 
  
http://www.biorestorative.com/
 Biorestorative Therapies & Auctus Fund LLC Joint
Reorganization Disclosure & Plan: 

http://www.biorestorative.com/wp-content/uploads/2020/07/PLAN-OF-REORGANIZATION.pdf
http://www.biorestorative.com/wp-content/uploads/2020/07/DISCLOSURE-STATEMENT-OF-REORGANIZATION.pdf

Biorestorative Therapies September 2019 Isreal & Australia Patents For Metabolic Stem Cell Program:

https://www.otcmarkets.com/stock/BRTXQ/news/BioRestorative-Therapies-Receives-Patent-in-Israel-For-Its-Metabolic-Program?id=249195
https://www.otcmarkets.com/stock/BRTXQ/news/BioRestorative-Therapies-Receives-A-Second-Patent-in-Australia-For-Its-Metabolic-Program?id=244017

 

BRTXQ PAGE 12 & 13 OF THEIR FDA PHASE 2 TRIAL PRESENTATION BELOW PRESENTATION
SHOWS THE LOW COST OF THEIR STEM CELL INJECTION
TREATMENT VERSES THE HIGH COST OF SURGICAL
TREATMENT. PAGE 13 ALSO SHOWS THAT 99 PEOPLE / SUBJECTS WILL BE ALLOWED BY THE FDA TO GET
INJECTIONS WITH THEIR BRTX-100 STEM CELL DRUG!!!


AS has been reduced to 75 mil from 300 bil per the 8-K filed on Nov 22, 2021

OS is currently 5,815,775

BRTX-100 Phase II Study is fully funded. Recruitment process has been intiated.

 
 
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post